Last reviewed · How we verify
NCT07015658
Clinical Effects of Moxibustion Combined With Tailored Baduanjin Exercise Programs on Early Postoperative Rehabilitation in Lumbar Disc Herniation Patients Undergoing Minimally Invasive Surgery
NA trial testing Baduanjin in Lumbar Disc Herniations in 120 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Suyun Liu |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 June 2025 |
| Primary completion | 30 September 2026 |
| Estimated completion | 30 December 2026 |
Drugs / interventions tested
- Baduanjin
- Moxibustion
- Conventional intervention
Conditions studied
- Lumbar Disc Herniations — all drugs for Lumbar Disc Herniations →
Sponsor
Suyun Liu
Who can join
18 and older, any sex, with Lumbar Disc Herniations. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a single-center randomized controlled trial, aiming to explore the effect of moxibustion combined with the modified Baduanjin exercise regimen on the early rehabilitation of patients with lumbar disc herniation (LDH) after minimally invasive surgery. A total of 120 patients were included in the study and randomly divided into the control group (conventional treatment and rehabilitation care), the Baduanjin group (conventional treatment + modified Baduanjin), and the combined intervention group (conventional treatment + Baduanjin + moxibustion). By comparing the visual pain scores (VAS), lumbar function scores (JOA), lumbar range of motion, and anxiety scale (HAMA) changes at 1 day, 1 month, and 3 months after surgery, the study evaluated the improvement effect of the integrated traditional Chinese medicine and Western medicine rehabilitation plan on postoperative pain relief, functional recovery, and psychological state. The study innovatively integrates the advantages of traditional Chinese medicine moxibustion for warming and promoting meridians and the low-intensity exercise of the modified Baduanjin, optimizes the difficulty of traditional rehabilitation training, and provides evidence-based basis for improving patient compliance and standardizing postoperative rehabilitation programs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07015658
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Baduanjin
Trials testing the same drug.
- NCT07524725 — Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on · NA · not yet recruiting
- NCT07259694 — RCT on Traditional Exercise Interventions for Physical and Mental Health in Hearing-Impaired Individuals · NA · enrolling by invitation
- NCT07265024 — Traditional Exercise RCT in Visually Impaired Adults · NA · enrolling by invitation
- NCT07109557 — The Effect of Baduanjin on Patients Undergoing Knee Replacement Surgery · NA · recruiting
- NCT06803459 — Effects of Baduanjin and PNF on Upper Crossed Syndrome Among University Students in Henan Province，China · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07015658 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suyun Liu
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07015658.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing